← Copart overview

Copart vs Wolters Kluwer: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Copart Inc (CPRT)

Q3 2026
▼2▲1

Copart buys ACV, founder returns, but weak results and probes weigh

  • Copart's $1.9B cash purchase of ACV Auctions Copart agreed to buy ACV Auctions for $1.9 billion in cash, adding 800,000 yearly dealer vehicle sales and reducing reliance on its shrinking U.S. insurance business, where volume fell 8% in fiscal 2026. The deal should add to profit by fiscal 2028.

    The largest strategic move of the quarter, reshaping Copart's business mix and growth outlook.

  • Founder Jay Adair returns as sole CEO Founder Jay Adair came back as sole CEO with backing from SVN Capital, while Copart holds $4.2 billion in cash and no debt. Leadership stability and a strong balance sheet support the ACV deal and future investment.

    A major leadership change that restores founder-led direction and reassures investors about execution.

  • Weak Q4 profit and soft full-year growth Fourth-quarter profit fell 17.4%, earnings per share missed expectations, margins shrank, and full-year revenue grew just 0.4%. The weak results highlight pressure on Copart's core insurance auction business.

    Directly shows deteriorating financial performance that weighs on the stock.

  • CEO exit triggers probes and analyst downgrade CEO Jeff Liaw's exit led to securities fraud investigations, a director sold 80,000 shares, and Barclays cut its price target to $25, citing declining insurance volumes. These events raise governance and demand concerns.

    Adds legal and reputational risk while analyst caution reflects underlying business challenges.

August 2026
▼2▲1

Copart's CEO Exit, Weak Q4, and $1.9B ACV Deal Drive the Story

  • CEO exit triggers securities fraud investigations Jeff Liaw's June 29 exit as CEO sent the stock down 8%, and law firms Pomerantz and Bragar Eagel & Squire are now investigating possible securities fraud. Legal uncertainty and leadership upheaval weigh on the stock.

    New investigations tied to the CEO departure are a fresh negative overhang on CPRT.

  • Director sells 80,000 shares Director Daniel Englander sold 80,000 shares for $2.2 million, cutting his holdings by 14%. Insider selling can signal executives see limited upside, and it adds to negative sentiment.

    A fresh insider sale is a new negative signal for investors.

  • Founder Jay Adair returns as sole CEO SVN Capital backs Jay Adair, a founding member, returning as sole CEO for at least a decade. He says lost insurance volume was one account, not a broken franchise. Copart has $4.2B cash and no debt.

    New leadership confidence and a strong balance sheet are a positive counterweight to the CEO exit.

  • $1.9B ACV deal adds dealer volume as insurance shrinks Copart will pay about $1.9B cash for ACV, adding 800,000 dealer vehicle sales a year. U.S. insurance volume fell 8% in fiscal 2026, so this diversifies away from a shrinking core. Breakeven at first, accretive by fiscal 2028.

    The ACV acquisition is the biggest strategic move this period, reshaping Copart's growth path.

Latest
▼2▲1

Copart's CEO Exit, Weak Q4, and $1.9B ACV Deal Drive the Story

  • CEO exit triggers securities fraud investigations Jeff Liaw's June 29 exit as CEO sent the stock down 8%, and law firms Pomerantz and Bragar Eagel & Squire are now investigating possible securities fraud. Legal uncertainty and leadership upheaval weigh on the stock.

    New investigations tied to the CEO departure are a fresh negative overhang on CPRT.

  • Director sells 80,000 shares Director Daniel Englander sold 80,000 shares for $2.2 million, cutting his holdings by 14%. Insider selling can signal executives see limited upside, and it adds to negative sentiment.

    A fresh insider sale is a new negative signal for investors.

  • Founder Jay Adair returns as sole CEO SVN Capital backs Jay Adair, a founding member, returning as sole CEO for at least a decade. He says lost insurance volume was one account, not a broken franchise. Copart has $4.2B cash and no debt.

    New leadership confidence and a strong balance sheet are a positive counterweight to the CEO exit.

  • $1.9B ACV deal adds dealer volume as insurance shrinks Copart will pay about $1.9B cash for ACV, adding 800,000 dealer vehicle sales a year. U.S. insurance volume fell 8% in fiscal 2026, so this diversifies away from a shrinking core. Breakeven at first, accretive by fiscal 2028.

    The ACV acquisition is the biggest strategic move this period, reshaping Copart's growth path.

September 2026
▲1▼1

Copart's $1.9B ACV Deal and Weak Q4 Profits Shape the Story

  • Copart to buy ACV Auctions for $1.9B Copart agreed to acquire digital auction platform ACV for $1.9 billion in cash, a 45% premium. The deal adds ACV's 800k annual vehicle sales and $10B merchandise value, expanding Copart's dealer auction reach. Funded from cash, it's expected to be accretive by fiscal 2028. Shares rose 7% on the news.

    This is the biggest new event, directly explaining the stock's recent jump and future growth path.

  • Q4 profit falls 17.4% as margins shrink Copart's fiscal Q4 net income dropped 17.4% to $327.4 million, and earnings per share fell to $0.35 from $0.41. Gross profit declined 5.5%. Full-year revenue barely grew, up 0.4%. The weak profit shows the core business is under pressure, which weighs on the stock.

    This is the key counterweight: despite the deal excitement, underlying profits are shrinking.

  • Q2 revenue beat but EPS missed; stock jumped 9.5% Copart's Q2 revenue of $1.15 billion beat estimates, but GAAP EPS of $0.35 missed the $0.38 consensus. Operating margin fell to 32% from 36.7%, and free cash flow margin dropped to 24.2%. Despite the miss, the stock jumped 9.5%, likely on the revenue beat and deal news.

    This earnings report shows the mixed fundamental picture that investors are weighing alongside the acquisition.

  • Copart in talks to buy CCC Intelligent Solutions Copart is reportedly in talks to acquire CCC, a digital claims platform, competing with private equity firms. The deal would combine Copart's salvage auctions with CCC's software. But Barclays cut its price target to $25 with an Underweight rating, citing potential volume declines from insurance contract changes.

    This potential acquisition adds another strategic move, but the analyst downgrade highlights risks.

▲1▼1

Copart's $1.9B ACV Deal and Weak Q4 Profits Shape the Story

  • Copart to buy ACV Auctions for $1.9B Copart agreed to acquire digital auction platform ACV for $1.9 billion in cash, a 45% premium. The deal adds ACV's 800k annual vehicle sales and $10B merchandise value, expanding Copart's dealer auction reach. Funded from cash, it's expected to be accretive by fiscal 2028. Shares rose 7% on the news.

    This is the biggest new event, directly explaining the stock's recent jump and future growth path.

  • Q4 profit falls 17.4% as margins shrink Copart's fiscal Q4 net income dropped 17.4% to $327.4 million, and earnings per share fell to $0.35 from $0.41. Gross profit declined 5.5%. Full-year revenue barely grew, up 0.4%. The weak profit shows the core business is under pressure, which weighs on the stock.

    This is the key counterweight: despite the deal excitement, underlying profits are shrinking.

  • Q2 revenue beat but EPS missed; stock jumped 9.5% Copart's Q2 revenue of $1.15 billion beat estimates, but GAAP EPS of $0.35 missed the $0.38 consensus. Operating margin fell to 32% from 36.7%, and free cash flow margin dropped to 24.2%. Despite the miss, the stock jumped 9.5%, likely on the revenue beat and deal news.

    This earnings report shows the mixed fundamental picture that investors are weighing alongside the acquisition.

  • Copart in talks to buy CCC Intelligent Solutions Copart is reportedly in talks to acquire CCC, a digital claims platform, competing with private equity firms. The deal would combine Copart's salvage auctions with CCC's software. But Barclays cut its price target to $25 with an Underweight rating, citing potential volume declines from insurance contract changes.

    This potential acquisition adds another strategic move, but the analyst downgrade highlights risks.

Wolters Kluwer N.V. (WKL.AS)

Q3 2026
▲4

Wolters Kluwer: AI product push and buybacks drive gains

  • AI-powered product launches and integrations Wolters Kluwer rolled out AI upgrades across its legal, tax, and health platforms: Libra AI Workspace, Libra Academy, Kluwer Law International content, CCH brand in Belgium, and Libra AI tools inside Poland's LEX. These deepen customer lock-in and support premium pricing, lifting future revenue and the stock.

    This is the main new growth driver this period, showing AI execution across multiple segments.

  • Strong H1 results with 5% organic growth Wolters Kluwer reported 5% organic revenue growth and 9% organic profit growth for H1 2026, with margin expanding to 29.4%. Recurring revenues, 85% of the total, grew 7%. AI adoption is boosting results, and full-year guidance was reiterated, reassuring investors.

    The earnings report is the single most important new fundamental event, confirming the company's growth trajectory.

  • New partnerships and contract renewals expand reach Wolters Kluwer renewed and expanded its Norway health deal for 30,000 clinicians, partnered with Hitachi Cyber to resell TeamMate, and integrated Capego with Finago in Sweden. These deals broaden distribution and add recurring revenue, supporting the stock.

    These are concrete new business wins that show demand for Wolters Kluwer's products beyond its core markets.

  • Ongoing share buybacks and capital reduction Wolters Kluwer continued its €500 million 2026 buyback, repurchasing shares regularly, and cancelled 7.8 million treasury shares, cutting issued capital to 224.7 million. Fewer shares can lift earnings per share and signal management confidence, supporting the price.

    Buybacks and capital reduction are a steady positive force on the share price and are a recurring theme this period.

August 2026
▲4

Wolters Kluwer: AI product push and buybacks drive gains

  • AI-powered product launches and integrations Wolters Kluwer rolled out AI upgrades across its legal, tax, and health platforms: Libra AI Workspace, Libra Academy, Kluwer Law International content, CCH brand in Belgium, and Libra AI tools inside Poland's LEX. These deepen customer lock-in and support premium pricing, lifting future revenue and the stock.

    This is the main new growth driver this period, showing AI execution across multiple segments.

  • Strong H1 results with 5% organic growth Wolters Kluwer reported 5% organic revenue growth and 9% organic profit growth for H1 2026, with margin expanding to 29.4%. Recurring revenues, 85% of the total, grew 7%. AI adoption is boosting results, and full-year guidance was reiterated, reassuring investors.

    The earnings report is the single most important new fundamental event, confirming the company's growth trajectory.

  • New partnerships and contract renewals expand reach Wolters Kluwer renewed and expanded its Norway health deal for 30,000 clinicians, partnered with Hitachi Cyber to resell TeamMate, and integrated Capego with Finago in Sweden. These deals broaden distribution and add recurring revenue, supporting the stock.

    These are concrete new business wins that show demand for Wolters Kluwer's products beyond its core markets.

  • Ongoing share buybacks and capital reduction Wolters Kluwer continued its €500 million 2026 buyback, repurchasing shares regularly, and cancelled 7.8 million treasury shares, cutting issued capital to 224.7 million. Fewer shares can lift earnings per share and signal management confidence, supporting the price.

    Buybacks and capital reduction are a steady positive force on the share price and are a recurring theme this period.

Latest
▲4

Wolters Kluwer: AI product push and buybacks drive gains

  • AI-powered product launches and integrations Wolters Kluwer rolled out AI upgrades across its legal, tax, and health platforms: Libra AI Workspace, Libra Academy, Kluwer Law International content, CCH brand in Belgium, and Libra AI tools inside Poland's LEX. These deepen customer lock-in and support premium pricing, lifting future revenue and the stock.

    This is the main new growth driver this period, showing AI execution across multiple segments.

  • Strong H1 results with 5% organic growth Wolters Kluwer reported 5% organic revenue growth and 9% organic profit growth for H1 2026, with margin expanding to 29.4%. Recurring revenues, 85% of the total, grew 7%. AI adoption is boosting results, and full-year guidance was reiterated, reassuring investors.

    The earnings report is the single most important new fundamental event, confirming the company's growth trajectory.

  • New partnerships and contract renewals expand reach Wolters Kluwer renewed and expanded its Norway health deal for 30,000 clinicians, partnered with Hitachi Cyber to resell TeamMate, and integrated Capego with Finago in Sweden. These deals broaden distribution and add recurring revenue, supporting the stock.

    These are concrete new business wins that show demand for Wolters Kluwer's products beyond its core markets.

  • Ongoing share buybacks and capital reduction Wolters Kluwer continued its €500 million 2026 buyback, repurchasing shares regularly, and cancelled 7.8 million treasury shares, cutting issued capital to 224.7 million. Fewer shares can lift earnings per share and signal management confidence, supporting the price.

    Buybacks and capital reduction are a steady positive force on the share price and are a recurring theme this period.